|
Dr. Lee was most recently the Vice President of Regulatory Affairs, for Acorda Therapeutics. Prior to Acorda Therapeutics from 2001 to 2003, Dr. Lee was Executive Director of Regulatory Affairs/Quality Assurance with ATON Pharmaceuticals (purchased by Merck in 2003). Prior to Aton, Dr. Lee was the Director of Regulatory Affairs/Quality Assurance for VION Pharmaceuticals from 1996 through 2001, and was the Manager of Regulatory Affairs/Clinical Affairs for IBEX Technologies from 1993 to 1996. Dr. Lee began his career in the pharmaceutical industry as a Research Investigator and later became a Senior Pharmacologist at Sterling-Winthrop from 1987 through 1993, and he was Research Supervisor at Wyeth-Ayerst from 1985 to 1986. Prior to his career in the pharmaceutical industry, Dr. Lee was a part-time academic faculty member of Eastern Kentucky University. Dr. Lee is a member of several professional societies including the Regulatory Affairs Professional Society and the Drug Information Association. He has been a guest speaker at several professional meetings, including the Annual Meeting and Workshop of the Society of Cardiovascular Anesthesiologists, the annual meeting of the Drug Information Association and the Annual Workshop at the Southern Connecticut State University. He has authored and co-authored over 40 publications (scientific and professional papers, books and review articles) and numerous scientific abstracts. Dr. Lee received his Ph.D. in Pharmacology from the University of Kentucky in 1983 and was certified by the Regulatory Affairs Professionals Board in 1994. | 